Invention Grant
- Patent Title: Formulations and methods for direct sodium removal in patients having severe renal dysfunction
-
Application No.: US17661737Application Date: 2022-05-02
-
Publication No.: US11559618B2Publication Date: 2023-01-24
- Inventor: Jeffrey Testani , Christopher McIntyre , Ian Crosbie , Oliver Goedje
- Applicant: Sequana Medical NV
- Applicant Address: BE Ghent
- Assignee: Sequana Medical NV
- Current Assignee: Sequana Medical NV
- Current Assignee Address: BE Ghent
- Agency: Eversheds Sutherland (US) LLP
- Agent Christopher C. Bolten; Nicola A. Pisano
- Main IPC: A61M1/28
- IPC: A61M1/28 ; A61P7/08 ; A61K33/14 ; A61K9/00 ; A61K9/08 ; A61K31/7004 ; A61K31/716 ; A61M27/00 ; A61M31/00 ; A61L2/00

Abstract:
A direct sodium removal (“DSR”) infusate regimen and methods of use are provided for removing sodium and reducing fluid overload in patients with severe renal dysfunction and/or heart failure, in which a patient has at least a first DSR session with a first DSR infusate having no or low sodium that is instilled into a patient's peritoneal cavity for a first dwell period to cause sodium and excess fluid to migrate to the patient's peritoneal cavity, and thereafter, the patient may undergo conventional dialysis to rebalance the patient's fluid and sodium levels.
Public/Granted literature
- US20220257843A1 FORMULATIONS AND METHODS FOR DIRECT SODIUM REMOVAL IN PATIENTS HAVING SEVERE RENAL DYSFUNCTION Public/Granted day:2022-08-18
Information query
IPC分类: